Kingdon Capital Management »

Genes shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of Genes (GCO) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.1M 244k 28.99

More positions owned by Kingdon Capital Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Syndax Pharmaceuticals (SNDX)
NVIDIA Corporation (NVDA)
Nexgen Energy (NXE)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Msci Sth Kor Etf (EWY)
Keysight Technologies (KEYS)
Warby Parker Cl A Com (WRBY)
Soleno Therapeutics (SLNO)
Api Group Corp Com Stk (APG)
Maplebear (CART)
Howmet Aerospace (HWM)
Ishares Tr Msci Usa Mmentm Put Option (MTUM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Everus Constr Group (ECG)

View all positions for Kingdon Capital Management

Top funds holding Genes

Pzena Investment Management
BlackRock
Vanguard Group
Dimensional Fund Advisors
Vanguard Capital Management
Acadian Asset Management
Fund 1 Investments
Charles Schwab Investment Management
Citadel Advisors
Healthcare Of Ontario Pension Plan Trust Fund
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Kingdon Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Genes